We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,436

After reconsideration, the Viagra patent is not void

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada
  • -
  • June 11 2013

Close to seven months after rendering its decision in Teva Canada Ltd v Pfizer Canada Inc., 2012 SCC 60, the Supreme Court of Canada varied its

New mental health safety standard may impact employers’ duties related to employee mental health

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 4 2013

Recent studies have shown that one in five Canadians will experience a mental illness in their lifetime, and that mental health is the number one

US Supreme Court releases Myriad, isolated DNA unpatentable what it means for Canada

  • Smart & Biggar/Fetherstonhaugh
  • -
  • Canada, USA
  • -
  • June 13 2013

The Supreme Court of the United States today issued its opinion in Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al., 569 U

Supreme Court varies VIAGRA ruling, confirms that patent is neither invalid nor void

  • Smart & Biggar/Fetherstonhaugh
  • -
  • Canada
  • -
  • June 6 2013

The Supreme Court of Canada has clarified its ruling in Teva Canada Ltd v Pfizer Canada Inc, 2012 SCC 60. The Court has confirmed that the patent in

Guidelines on medical uses released by the Patent Office

  • Marks & Clerk LLP
  • -
  • Canada
  • -
  • June 13 2013

On June 10, 2013, the Canadian Intellectual Property Office (CIPO) released examination guidelines on medical use claims. In particular, the

IP in the life sciences industries 2013

  • Intellectual Asset Management magazine
  • -
  • Canada, Germany, India, Mexico, Sweden, USA
  • -
  • May 24 2013

No matter what stage of the business cycle they have reached, it is critical for companies in the life sciences sector to identify, protect and

Supreme Court denies leave in Takeda Canada Inc. v. Minister of Health, Attorney General of Canada

  • Bereskin & Parr LLP
  • -
  • Canada
  • -
  • June 14 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal (the "FCA") decision in Takeda Canada Inc. v. Minister of

Nova Scotia now has personal health information protection legislation

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 10 2013

On June 1, 2013, Nova Scotia's Personal Health Information Act, SNS 2010, c 41 along with the Personal Health Information Regulations, NS Reg

Supreme Court amends earlier decision: Viagra patent not void

  • Bereskin & Parr LLP
  • -
  • Canada
  • -
  • June 6 2013

In Teva Canada Ltd v Pfizer Canada Inc, the Supreme Court of Canada (the "SCC") held Pfizer's Canadian Patent No. 2,163,446 (the '446 Patent) to be

New electronic health records legislation on the horizon in Ontario

  • McCarthy Tétrault LLP
  • -
  • Canada
  • -
  • June 5 2013

The Liberal government in Ontario has introduced significant new amendments to its health privacy legislation, the Personal Health Information

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy